Literature DB >> 26275437

Characterization of an acromesomelic dysplasia, Grebe type case: novel mutation affecting the recognition motif at the processing site of GDF5.

Monica Martinez-Garcia1,2, Eva Garcia-Canto3, Maria Fenollar-Cortes4, Antonio Perez Aytes5,6, María José Trujillo-Tiebas7,8.   

Abstract

Acromesomelic dysplasia, Grebe type is a very rare skeletal dysplasia characterized by severe dwarfism with marked micromelia and deformation of the upper and lower limbs, with a proximodistal gradient of severity. CDMP1 gene mutations have been associated with Grebe syndrome, Hunter-Thompson syndrome, Du Pan syndrome and brachydactyly type C. The proband is a 4-year-old boy, born of consanguineous Pakistani parents. Radiographic imaging revealed features typical of Grebe syndrome: severe shortening of the forearms with an acromesomelic pattern following a proximodistal gradient, with distal parts more severely affected than medial parts; hypoplastic hands, with the phalangeal zone more affected than the metacarpal zone; and severe hypoplastic tibial/femoral zones in both limbs. After molecular analyses, the p.Arg377Trp variant in a homozygous pattern was identified in the CDMP1 gene in the affected child. In silico and structural analyses predicted the p.Arg377Trp amino acid change to be pathogenic. Of the 34 mutations described in the CDMP1 gene, four different missense mutations have been associated with Grebe syndrome. The CDMP1 gene encodes growth differentiation factor 5 (GDF5), which plays a role in regulation of limb patterning, joint formation and distal bone growth. Homozygous mutations in the mature domain of GDF5 result in severe limb malformations such as the Grebe type or the Hunter-Thompson type of acromesomelic chondrodysplasia. The p.Arg377Trp mutation is located within the recognition motif at the processing site of GDF5 where the sequence RRKRR changes to WRKRR. The genotype-phenotype correlation allowed not only confirmation of the clinical diagnosis but also appropriate genetic counselling to be offered to this family.

Entities:  

Keywords:  CDMP1; Grebe; Growth differentiation factor 5; Pakistan; Skeletal

Mesh:

Substances:

Year:  2015        PMID: 26275437     DOI: 10.1007/s00774-015-0693-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  10 in total

1.  Grebe syndrome: clinical and radiographic findings in affected individuals and heterozygous carriers.

Authors:  T Costa; G Ramsby; F Cassia; K R Peters; J Soares; J Correa; A Quelce-Salgado; P Tsipouras
Journal:  Am J Med Genet       Date:  1998-02-17

Review 2.  Cartilage-derived morphogenetic protein-1.

Authors:  F P Luyten
Journal:  Int J Biochem Cell Biol       Date:  1997-11       Impact factor: 5.085

3.  Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1.

Authors:  J T Thomas; M W Kilpatrick; K Lin; L Erlacher; P Lembessis; T Costa; P Tsipouras; F P Luyten
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

4.  Genetic counseling and risk communication services of newborn screening programs.

Authors:  M Farrell; L Certain; P Farrell
Journal:  Arch Pediatr Adolesc Med       Date:  2001-02

5.  Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development.

Authors:  S C Chang; B Hoang; J T Thomas; S Vukicevic; F P Luyten; N J Ryba; C A Kozak; A H Reddi; M Moos
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

6.  Brachydactyly type A2 associated with a defect in proGDF5 processing.

Authors:  Frank Plöger; Petra Seemann; Mareen Schmidt-von Kegler; Katarina Lehmann; Jörg Seidel; Klaus W Kjaer; Jens Pohl; Stefan Mundlos
Journal:  Hum Mol Genet       Date:  2008-01-18       Impact factor: 6.150

7.  Compound heterozygosity for GDF5 in Du Pan type chondrodysplasia.

Authors:  Sofia Douzgou; Katarina Lehmann; Rita Mingarelli; Stefan Mundlos; Bruno Dallapiccola
Journal:  Am J Med Genet A       Date:  2008-08-15       Impact factor: 2.802

8.  Mechanisms of GDF-5 action during skeletal development.

Authors:  P H Francis-West; A Abdelfattah; P Chen; C Allen; J Parish; R Ladher; S Allen; S MacPherson; F P Luyten; C W Archer
Journal:  Development       Date:  1999-03       Impact factor: 6.868

9.  A novel insertion mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene underlies Grebe-type chondrodysplasia in a consanguineous Pakistani family.

Authors:  Sulman Basit; Syed Kamran-ul-Hassan Naqvi; Naveed Wasif; Ghazanfar Ali; Muhammad Ansar; Wasim Ahmad
Journal:  BMC Med Genet       Date:  2008-11-27       Impact factor: 2.103

Review 10.  Communicating genetic information: a difficult challenge for future pediatricians.

Authors:  Eduardo Rosas-Blum; Pratibha Shirsat; Marie Leiner
Journal:  BMC Med Educ       Date:  2007-06-18       Impact factor: 2.463

  10 in total
  5 in total

1.  Association between GDF5 +104T/C polymorphism and knee osteoarthritis in Caucasian and Asian populations: a meta-analysis based on case-control studies.

Authors:  Dong Jiang; Zengtao Hao; Dongsheng Fan; Wen Guo; Pengcheng Xu; Chao Yin; Shuzheng Wen; Jihong Wang
Journal:  J Orthop Surg Res       Date:  2016-09-23       Impact factor: 2.359

Review 2.  The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications.

Authors:  Bethanie I Ayerst; Catherine L R Merry; Anthony J Day
Journal:  Pharmaceuticals (Basel)       Date:  2017-06-13

3.  Genetic regulation of linear growth.

Authors:  Shanna Yue; Philip Whalen; Youn Hee Jee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2019-03-31

Review 4.  "Lessons from Rare Forms of Osteoarthritis".

Authors:  Rebecca F Shepherd; Jemma G Kerns; Lakshminarayan R Ranganath; James A Gallagher; Adam M Taylor
Journal:  Calcif Tissue Int       Date:  2021-08-21       Impact factor: 4.333

5.  Knock-in human GDF5 proregion L373R mutation as a mouse model for proximal symphalangism.

Authors:  Xinxin Zhang; Xuesha Xing; Xing Liu; Yu Hu; Shengqiang Qu; Heyi Wang; Yang Luo
Journal:  Oncotarget       Date:  2017-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.